首页> 美国卫生研究院文献>ACS AuthorChoice >Multiplex Detection of Functional G Protein-Coupled ReceptorsHarboring Site-Specifically Modified Unnatural Amino Acids
【2h】

Multiplex Detection of Functional G Protein-Coupled ReceptorsHarboring Site-Specifically Modified Unnatural Amino Acids

机译:功能性G蛋白偶联受体的多重检测含有特定位点修饰的非天然氨基酸

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We developed a strategy for identifying positions in G protein-coupled receptors that are amenable to bioorthogonal modification with a peptide epitope tag under cell culturing conditions. We introduced the unnatural amino acid p-azido-l-phenylalanine (azF) into human CC chemokine receptor 5 (CCR5) at site-specific amber codon mutations. We then used strain-promoted azide–alkyne [3+2] cycloaddition to label the azF-CCR5 variants with a FLAG peptide epitope-conjugated aza-dibenzocyclooctyne (DBCO) reagent. A microtiter plate-based sandwich fluorophore-linked immunosorbent assay was used to probe simultaneously the FLAG epitope and the receptor using infrared dye-conjugated antibodies so that the extent of DBCO incorporation, corresponding nominally to labeling efficiency, could be quantified ratiometrically. The extent of incorporation of DBCO at the various sites was evaluated in the context of a recent crystal structure of maraviroc-bound CCR5. We observed that labeling efficiency varied dramatically depending on the topological location of the azF in CCR5. Interestingly, position109 in transmembrane helix 3, located in a hydrophobic cavity on theextracellular side of the receptor, was labeled most efficiently.Because the bioorthogonal labeling and detection strategy describedmight be used to introduce a variety of different peptide epitopesor fluorophores into engineered expressed receptors, it might proveto be useful for a wide range of applications, including single-moleculedetection studies of receptor trafficking and signaling mechanism.
机译:我们开发了一种策略,用于识别在细胞培养条件下适合于用肽表位标签进行生物正交修饰的G蛋白偶联受体中的位置。我们将非天然氨基酸p-叠氮基-1-苯丙氨酸(azF)引入了位点特异性琥珀密码子突变的人CC趋化因子受体5(CCR5)中。然后,我们使用应变促进的叠氮化物-炔烃[3 + 2]环加成反应,以FLAG肽表位偶联的aza-dibenzocyclooctyne(DBCO)试剂标记azF-CCR5变体。使用基于微量滴定板的夹心荧光团连接的免疫吸附测定法,使用红外染料偶联抗体同时探测FLAG表位和受体,以便可以按比例定量DBCO掺入的程度,名义上与标记效率相对应。在结合马拉维罗克的CCR5的最新晶体结构的背景下,评估了DBCO在不同位点的结合程度。我们观察到,标记效率的变化取决于CCR5中azF的拓扑位置。有趣的是,位置109在跨膜螺旋3中,位于受体的细胞外侧,被最有效地标记。因为描述了生物正交标记和检测策略可能用于引入各种不同的肽表位或荧光团转化为工程表达受体,这可能证明适用于包括单分子在内的广泛应用受体运输和信号传导机制的检测研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号